Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation

Surgery

Volumn 146, Issue 2, 2009, Pages 166-173

  Ashokkumar, Chethan ^a   Gupta, Ankit ^a   Sun, Qing ^a   Ningappa, Mylarappa B ^a   Higgs, Brandon W ^a   Mazariegos, George ^a   Fazzolare, Tamara ^a   Remaley, Lisa ^a   Soltys, Kyle ^a   Bond, Geoffrey ^a   Abu Elmagd, Kareem ^a   Sindhi, Rakesh ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTESTINE TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MALE; MEMORY CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMALL INTESTINE;

CD40 LIGAND; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; ISOANTIGENS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TACROLIMUS;

EID: 67650544201     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.04.006     Document Type: Article

References (20)

1. Abu-Elmagd K., Reyes J.R., Bond G., Mazariegos G., Wu T., Murase N., et al. Clinical intestinal transplantation: a decade of single center experience. Ann Surg 234 (2001) 404-416 discussion 416-7
2. Bond G.J., Mazariegos G.V., Sindhi R., Abu-Elmagd K.M., and Reyes J. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg 40 (2005) 274-279 discussion 279-80
3. Reyes J., Mazariegos G.V., Abu-Elmagd K., Macedo C., Bond G.J., Murase N., et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 5 (2005) 1430-1436
4. Kerman R.H., Susskind B., Katz S.M., Van Buren C.T., and Kahan B.D. Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders. Transplant Proc 29 (1997) 1410-1411
5. Sindhi R., Magill A., Abdullah A., Seward J., Tresgaskes M., Bentlejewski C., et al. Enhanced donor-specific alloreactivity occurs independent of immunosuppression in children with early liver allograft rejection. Am J Transplant 5 (2005) 96-102
6. Khera N., Janosky J., Zeevi A., Mazariegos G., Marcos A., and Sindhi R. Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children. Front Biosci 1 (2007) 660-663
7. Gebauer B.S., Hricik D.E., Atallah A., Bryan K., Riley J., Tary-Lehmann M., et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2 (2002) 857-866
8. Ashokumar C., Talukdar A., Sun Q., Higgs B.W., Janosky J., Wilson P., et al. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 9 (2009) 179-191
9. Schönbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58 (2001) 4-43
10. Iwakoshi N.N., Mordes J.P., Markees T.G., Phillips N.E., Rossini A.A., and Greiner D.L. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 164 (2000) 512-521
11. Dai Z., and Lakkis F.G. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. Curr Opin Immunol 11 (1999) 504-508
12. Issazadeh S., Navikas V., Schaub M., Sayegh M., and Khoury S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol 161 (1998) 1104-1112
13. Im S.H., Barchan D., Maiti P.K., Fuchs S., and Souroujon M.C. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. J Immunol 166 (2001) 6893-6898
14. Chattopadhyay P.K., Yu J., and Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 11 (2005) 1113-1117
15. + T cells specific for defined antigens according to CD154 expression. Nat Med 11 (2005) 1118-1124
16. Hosmer D., and Lemeshow S. Applied logistic regression. 2nd ed (2000), Wiley, New York
17. Nagelkerke N.J.D. A note on a general definition of the coefficient of determination. Biometrika 78 (1991) 691-692
18. Bautista D., Arana E., Martí-Bonmatí L., and Paredes R. Validation of logistic regression models in small samples: application to calvarial lesions diagnosis. J Clin Epidemiol 52 (1999) 237-241
19. Fawcett T. An introduction to ROC analysis. Pattern Recogn Lett 27 (2006) 861-874
20. Taguchi O., Kontani K., Ikeda H., Kezuka T., Takeuchi M., Takahashi T., et al. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 82 (1994) 365-369